跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dilatair - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dilatair
Approved
STANDARD
Dilatair
Ajanta Pharma Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
69f55560a7f7cb94
Company
Ajanta Pharma Ltd.
Type
Standard
Approval Details
Approval Id
69f55560a7f7cb94
Drug Approval Philippines Name
Dilatair
Product Name
Dilatair
Registration Number
DR-XY42871
Brand Name
Dilatair
Generic Name
Doxofylline
Dosage Form
Tablet
Dosage Strength
400 mg
Manufacturer
Ajanta Pharma Ltd.
Importer
The Cathay Drug Company, Inc
Distributor
The Cathay Drug Company, Inc
Company Detail Path
/organization/ajanta-pharma-ltd
Issuance Date
04 August 2023
Expiry Date
24 November 2028
Pharmacologic Category
Drug for Obstructive Airway Disease (Xanthines)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
69f55560a7f7cb94
Type
Standard
Back to Philippines FDA Approvals